Funding Archives - Page 3 of 6 -

Mergers and acquisitions in digital health bounced back strongly in Q2 after almost grinding to a halt at

Digital health M&A bounces back in Q2

https://pharmaphorum.com/news/digital-health-ma-bounces-back-in-q2/

News/ News/ R&D

UK biotech investor Arix looks for new CEO

Richard Staines Arix, Biotech, Funding, jobs 0 Comment

UK biotech investor Arix Bioscience is looking for a new CEO after Joe Anderson decided to focus on

UK biotech investor Arix looks for new CEO

https://pharmaphorum.com/news/uk-biotech-investor-arix-looks-for-new-ceo/

Partner content/ Press releases/ R&D

How challenges like Brexit & insufficient patients hinder Rare Diseases research

Lyudmyla Durneva collaboration, Funding, orphan drugs, patient organisations, Rare diseases 0 Comment

Challenges facing Orphan Drugs & Rare Diseases Research

How challenges like Brexit & insufficient patients hinder Rare Diseases research

https://pharmaphorum.com/partner-content/how-challenges-like-brexit-insufficient-patients-hinder-rare-diseases-research/

Google’s Verily eyes 2021 growth after £700m funding round

News/ News/ News/ R&D/ Startups/ US

Microsoft and Google among funders for cloud-based R&D startup

Richard Staines digital health, Funding, Google, Microsoft 0 Comment

DNAnexus focuses on cloud-based R&D

Microsoft and Google among funders for cloud-based R&D startup

https://pharmaphorum.com/news/microsoft-google-dnanexus/

Digital/ News/ News/ News/ Startups/ US

US investor looks to back new digital health startups

Richard Staines digital health, digital startups, Funding 0 Comment

Digital health entrepreneurs will get the chance to test and expand their businesses as part of an initiative

US investor looks to back new digital health startups

https://pharmaphorum.com/news/us-investor-looks-back-new-digital-health-startups/

Cancer/ Quintiles - Oncol articles/ Views and analysis

Biosimilars in oncology: a €2billion opportunity for European healthcare

Marco Ricci biosimilars, cancer, Funding, healthcare, IQVIA, Oncology, quintilesIMS 0 Comment

IQVIA’s Murray Aitken examines the potential for savings from a new wave of oncology biosimilars – but says

Biosimilars in oncology: a €2billion opportunity for European healthcare

https://pharmaphorum.com/views-and-analysis/biosimilars-oncology-european-healthcare/

News/ UK & Europe

NHS op waiting figures spark calls for more investment

Richard Staines Funding, NHS, politics 0 Comment

Health service in desperate need of investment, says think tank.

NHS op waiting figures spark calls for more investment

https://pharmaphorum.com/news/nhs-op-waiting/

Healthcare/ News/ UK & Europe

Theresa May backtracks on ‘Dementia tax’

Richard Staines dementia, dementia tax, Funding, general election 2017, legislation, NHS, social care 0 Comment

Parties take out rival ads as social care funding row escalates.

Theresa May backtracks on ‘Dementia tax’

https://pharmaphorum.com/news/conservatives-labour-dementia-tax-google-ad/

News/ UK & Europe

Pharma welcomes dialogue with politicians ahead of election

Richard Staines Brexit, election 2017, Funding, National Health Service 0 Comment

Conservative and Labour politicians assure industry with warm words at conference.

Pharma welcomes dialogue with politicians ahead of election

https://pharmaphorum.com/news/pharma-welcomes-dialogue-politicians-ahead-election/

Trending

Funding

Login